• LAST PRICE
    0.1405
  • TODAY'S CHANGE (%)
    Trending Down-0.0046 (-3.1702%)
  • Bid / Lots
    0.1400/ 3
  • Ask / Lots
    0.1509/ 69
  • Open / Previous Close
    0.1500 / 0.1451
  • Day Range
    Low 0.1365
    High 0.1521
  • 52 Week Range
    Low 0.1052
    High 1.0100
  • Volume
    342,440
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.1451
TimeVolumeELOX
09:32 ET100330.1496
09:42 ET104000.1495
09:44 ET10000.1473
09:50 ET4000.1452
10:00 ET14000.147284
10:02 ET85070.146
10:04 ET1013080.1399
10:06 ET344590.137
10:08 ET53000.145
10:11 ET42140.1371
10:18 ET2600.138
10:24 ET1000.1409
10:26 ET2500.1385
10:29 ET1000.1436
10:36 ET1000.140101
10:38 ET40570.1451
10:40 ET3000.1499
10:42 ET2000.14999
10:47 ET12000.1475
10:54 ET37010.1481
10:56 ET50000.1485
10:58 ET2000.1489
11:23 ET43930.1412
11:25 ET75770.139
11:27 ET190000.1381
11:32 ET598810.15
11:36 ET1000.15
11:41 ET20000.1477
11:43 ET7500.1477
11:57 ET4200.1477
12:03 ET9000.15
12:12 ET18180.1405
12:14 ET14000.14505
12:17 ET3000.14505
12:19 ET2000.14505
12:21 ET12000.1449
12:26 ET8510.140201
12:33 ET8400.1402
12:35 ET1580.1472
12:37 ET6800.1496
12:42 ET24720.1402
12:44 ET2500.14
12:46 ET14000.14
12:51 ET67000.145098
12:53 ET178240.1449
12:55 ET46970.1405
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesELOX
Eloxx Pharmaceuticals Inc
12.2M
-0.3x
---
United StatesNEXI
Neximmune Inc
12.0M
-0.2x
---
United StatesTCDA
Tricida Inc
11.9M
-0.1x
---
United StatesDFFN
Diffusion Pharmaceuticals Inc
12.6M
-0.8x
---
United StatesBPTH
Bio Path Holdings Inc
11.6M
-0.7x
---
United StatesIPIX
Innovation Pharmaceuticals Inc
11.4M
-1.8x
---
As of 2022-11-26

Company Information

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on ribosome modulation, by leveraging its TURBO-ZM chemistry technology platform and its library of aminoglycosides in developing oral small molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs), for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations. The Company's lead product candidate, ELX-02, is a small molecule designed to restore production of full-length functional proteins. ELX-02 is an investigational ERSG designed based on aminoglycoside antibiotics, such as gentamicin, with increased selectivity for the eukaryotic ribosome. The Company's preclinical programs are focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, including autosomal dominant polycystic kidney disease, as well as rare ocular genetic disorders.

Contact Information

Headquarters
480 ARSENAL WAY, SUITE 130WATERTOWN, MA, United States 02472
Phone
781-577-5300
Fax
302-636-5454

Executives

Independent Chairman of the Board
Tomer Kariv
President, Chief Executive Officer, Director
Sumit Aggarwal
Interim Chief Financial Officer, Principal Accounting Officer
Daniel Geffken
Head - Research and Development
Vijay Modur
Director
Lindsay Androski

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$12.2M
Revenue (TTM)
$0.00
Shares Outstanding
86.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.08
EPS
$-0.48
Book Value
$0.26
P/E Ratio
-0.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.